Marshall Wace North America’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$942K Sell
94,707
-4,393
-4% -$43.6K ﹤0.01% 944
2021
Q2
$986K Sell
99,100
-400,898
-80% -$3.98M ﹤0.01% 1013
2021
Q1
$4.92M Buy
+499,998
New +$5.12M 0.02% 570

Other funds holding DCGO

Marshall Wace North America's DCGO Position: Q3 2021 in Review

Marshall Wace North America reduced its DocGo (DCGO) stake by 4.4% in Q3 2021, selling an estimated $43.6K and leaving 94,707 shares worth $942K. The position accounts for ﹤0.01% of the portfolio, ranked #944.

Marshall Wace North America first reported a position in DCGO in Q1 2021 and has held it in 3 quarters since. The position peaked at $4.92M in Q1 2021. 41 funds tracked by Wall St. Rank hold DCGO as of Q3 2021.

  • Marshall Wace North America held 94,707 shares of DocGo worth $942K as of Q3 2021.
  • Marshall Wace North America sold 4,393 DocGo shares in Q3 2021, an estimated $43.6K.
  • DocGo made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #944 holding.
  • Marshall Wace North America first reported a position in DocGo in Q1 2021 and has held it in 3 quarters since.
  • Marshall Wace North America's DocGo position peaked at $4.92M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held DocGo as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.